Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial

Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The VOYAGER Phase 3 study record for avapritinib versus regorafenib in advanced GIST is displayed, with study details, results measures, eligibility information, and participating locations.
    Difference
    97%
    Check dated 2026-11-11T20:48:31.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T21:48:39.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The study page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-21T22:04:21.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-14T22:08:09.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T22:20:10.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error in place of the study details, blocking access to the study record and related information on the page. This reflects a permission or server error that prevents users from viewing study data or documents.
    Difference
    17%
    Check dated 2026-09-23T22:03:03.000Z thumbnail image

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.